Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection

M Saeftel1, B Fleischer, A Hoerauf

  • 1Department of Immunology, Bernhard Nocht Institute for Tropical Medicine, 20359 Hamburg, Germany.

Infection and Immunity
|March 20, 2001
PubMed

Insights

Nitric oxide (NO) is crucial for controlling Trypanosoma cruzi early in infection. However, inhibiting NO production later in acute or chronic Chagas

Area of Science:

  • Immunology
  • Parasitology
  • Infectious Diseases

Background:

  • Trypanosoma cruzi causes Chagas' disease.
  • Gamma interferon-activated macrophages kill T. cruzi via nitric oxide (NO).
  • Mice lacking inducible nitric oxide synthase (iNOS) are susceptible to T. cruzi.

Purpose of the Study:

  • To determine if NO production is essential for controlling T. cruzi throughout all infection phases.
  • To investigate the role of iNOS inhibition at different time points post-infection.

Main Methods:

  • BALB/c mice infected with T. cruzi.
  • Treatment with iNOS inhibitors (aminoguanidine or L-NIL) at various times post-infection.
  • Monitoring parasitemia and tissue amastigotes.

Main Results:

  • Early iNOS inhibition led to 100% mortality.
  • Late acute phase iNOS inhibition allowed parasite clearance and survival.
  • Chronic phase iNOS inhibition did not cause parasitemia reappearance.

Conclusions:

  • NO is essential for early acute T. cruzi infection control.
  • NO is dispensable in late acute and chronic phases of T. cruzi infection.
  • T. cruzi control mechanisms differ from other Kinetoplastida infections.

Related Concept Videos

American Trypanosomiasis01:22

American Trypanosomiasis

Chagas disease, or American trypanosomiasis, is a vector-borne parasitic infection caused by Trypanosoma cruzi, a flagellated protozoan (kinetoplastid) of the family Trypanosomatidae. The disease is endemic in Latin America, although cases are increasingly reported worldwide due to human migration. Transmission most commonly occurs when feces of infected triatomine bugs contaminate bite wounds or mucosal surfaces; additional routes include congenital, transfusional, transplant-related, and oral...
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure to...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Leishmaniasis01:30

Leishmaniasis

Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...